Pfizer Inc has said its experimental vaccine is more than 90 per cent effective in preventing Covid-19 based on initial data from a large study, Reuters reported.

Pfizer and German partner BioNTech SE are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine. The companies said they have so far found no serious safety concerns and expect to seek US emergency use authorisation later this month.